Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
2015 - Ng CK,Martelotto LG,Gauthier A,Wen HC,Piscuoglio S,Lim RS,Cowell CF,Wilkerson PM,Wai P,Rodrigues DN,Arnould L,Geyer FC,Bromberg SE,Lacroix-Triki M,Penault-Llorca F,Giard S,Sastre-Garau X,Natrajan R,Norton L,Cottu PH,Weigelt B,Vincent-Salomon A,Reis-Filho JS Genome Biol n°16(1) - pp 107
Involvement of IL17A, IL17F and IL23R polymorphism in colorectal cancer therapy
2015 - Omrane I,Medimegh I,Baroudi O,Ayari H,Bedhiafi W,Stambouli N,Ferchichi M,Kourda N,Bignon YJ,Uhrhammer N,Mezlini A,Ougatef K,Benammar-Elgaaied A PLoS One n°10(6) - pp 1
Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer Therapy
2015 - Omrane I,Medimegh I,Baroudi O,Ayari H,Bedhiafi W,Stambouli N,Ferchichi M,Kourda N,Bignon YJ,Uhrhammer N,Mezlini A,Bougatef K,Benammar-Elgaaied A PLoS One n°10 - pp 1
Is It Important to Adapt Neoadjuvant Chemotherapy to the Visible Clinical Response? An Open Randomized Phase II Study Comparing Response-Guided and Standard Treatments in HER2-Negative Operable Breast Cancer.
2015 - Wang-Lopez Q,Mouret-Reynier MA,Savoye AM,Abrial C,Kwiatkowski F,Garbar C,Dubray-Longeras P,Eymard JC,Lebouedec G,Vanpraagh I,Penault-Llorca F,Chollet P,Cure H Oncologist n°30 - pp 1
Lobular invasive breast cancer prognostic factors: About 940 patients
2015 - Jauffret C,Houvenaeghel G,Classe JM,Garbay JR,Giard S,Charitansky H,Cohen M,Bélichard C,Faure C,Darai É,Hudry D,Azuar P,Villet R,Gimbergues P,Tunon de Lara C,Martino M,Coutant C,Dravet F,Chauvet MP,Chereau Ewald E,Penault-Llorca F,Goncalves A,Lambaudie E Gynecol Obstet Fertil n°43 - pp 712-7
Middle interhemispheric variant of holoprosencephaly and partial 21q monosomy
2015 - Tran Mau-Them A, Goumy C,Delabaere A,Laurichesse-Delmas H,Lemery D,Gallot D Gynecol Obstet Fertil n°20 - pp 1
Morbidity of pelvic lymphadenectomy and para-aortic lymphadenectomy in endometrial cancer
2015 - Agar N, Philippe AC, Bourdel N, Rabischong B, Canis M, Le Bouedec G, Mulliez A, Dauplat J, Pomel C Bull Cancer n°102(5) - pp 428-435
Multicentric neoadjuvant pilot phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer
2015 - Nabholtz JM,Chalabi N,Radosevic-Robin N,Dauplat MM,Mouret-Reynier MA,Van-Praagh I,Servent V,Jacquin JP,Benmammar KE,Kullab S,Bahadoor MR,Kwiatkowski F,Cayre A,Abrial C,Durando X,Bignon YJ,Chollet P,Penault-Llorca F Int J Cancer n°9 - pp 1
Mutation analysis of PALB2 gene in French breast cancer families
2015 - Damiola F,Schultz I,Barjhoux L,Sornin V,Dondon MG,Marchais S,Marcou M,Caron O,Gauthier-Villars M,Depauw A,Luporsi E,Berthet P,Delnatte C,Bonadona V,Maugard C,Pujol P,Lasset C,Longy M,Bignon YJ,Fricker JP,Andrieu N,Sinilnikova OM,Stoppa-Lyonnet D,Mazoyer S,Muller D Breast Cancer Res Treat n°154 - pp 463-71
Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features
2015 - Mathieu R,Pignot G,Ingles A,Crepel M,Bigot P,Bernhard JC,Joly F,Guy L,Ravaud A,Azzouzi AR,Gravis G,Chevreau C,Zini L,Lang H,Pfister C,Lechevallier E,Fais PO,Berger J,Vayleux B,Roupret M,Audenet F,Descazeaud A,Rigaud J,Machiels JP,Staehler M,Salomon L,Ferriere JM,Kleinclauss F,Bensalah K,Patard JJ Urol Oncol n°15 - pp 1
Occult cancer in specimens of reduction mammaplasty aimed at symmetrization. A multicentric study of 2718 patients
2015 - Sorin T,Fyad JP,Delay E,Rouanet P,Rimareix F,Houpeau JL,Classe JM,Garrido I,Tunondelara C,Dauplat J,Bendavid C,Houvenaeghel H,Clough KB,Sarfati I,Leymarie N,Trudel M,Salleron J,Guillemin F,Oldrini G,Brix M,Dolivet G,Simon E,Verhaeghe JL,Marchal F Breast n°11 - pp 1
Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial
2015 - Michaud E,Evrard B,Pereira B,Rochette E,Bernard L,Rouzaire PO,Gourdon-Dubois N,Merlin E,Fauquert JL Trials n°16 - pp 197
Preanalytical, analytical, gestational and pediatric aspects of the S100B immuno-assays
2015 - Bouvier D,Duret T,Rouzaire P,Jabaudon M,Rouzaire M,Nourrisson C,Bourgne C,Pereira B,Evrard B,Sapin V Clin Chem Lab Med n°17 - pp 1
Prenatal BoBsTM in the cytogenetic analysis of products of spontaneous miscarriage
2015 - Mellali S,Haoud K,Gouas L,Khaled MB,Vago P,Moulessehoul S S Afr Med J n°105 - pp 870-3
Prenatal diagnosis of the VACTERL association using routine ultrasound examination
2015 - Debost-Legrand A,Goumy C,Laurichesse-Delmas H,Dechelotte P,Perthus I,Francannet C,Lemery D,Gallot D Birth Defects Res A Clin Mol Teratol n°2 - pp 1
Prenatal Screening of 21 Microdeletion/Microduplication Syndromes and Subtelomeric Imbalances by MLPA in Fetuses with Increased Nuchal Translucency and Normal Karyotype
2015 - Gouas L,Kemeny S,Beaufrere AM,Eymard-Pierre E,Pebrel-Richard C,Tchirkov A,Lemery D,Laurichesse-Delmas H,Vago P,Goumy C Cytogenet Genome Res n°146 - pp 28-32
Prevalence of recurrent pathogenic microdeletions and microduplications in over 9,500 pregnancies
2015 - Grati F,Molina-Gomes D,Ferreira JC,Dupont C,Alesi V,Gouas L,Horelli-Kuitunen N,Choy KW,Martínezconejero JA,Gonzales-de-la-Vega A,Piotrowski K,Genesio R,Queipo G,Malvestiti B,Herve B,Benzacken B,Novelli A,Vago P,Piippo K,Leung TY,Malvestiti F,Quibel T,Tabet AC,Simoni G,Vialard F Prenat Diagn n°11 - pp 1
Previous radiation for prostate neoplasm alters surgical and oncologic outcomes after rectal cancer surgery
2015 - Guandalino M,Dupre A,Francois M,Leroy B,Antomarchi O,Buc E,Dubois A,Guy L,Pezet D,Gagniere J J Surg Oncol n°29 - pp 1
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015 - Senkus E,Kyriakides S,Ohno S,Penault-Llorca F,Poortmans P,Rutgers E,Zackrisson S,Cardoso F Ann Oncol n°26 - pp 8-30
Prognostic Factors in Operable Breast Cancer Treated with Neoadjuvant Chemotherapy: Towards a Quantification of Residual Disease
2015 - Mombelli S,Kwiatkowski F,Abrial C,Wang-Lopez Q,Deboissieu P,Garbar C,Bensussan A,Cure H Oncology n°8 - pp 1